scispace - formally typeset
H

Hiranthi Jayasuriya

Researcher at Merck & Co.

Publications -  57
Citations -  3387

Hiranthi Jayasuriya is an academic researcher from Merck & Co.. The author has contributed to research in topics: Platensimycin & Farnesyl Protein Transferase. The author has an hindex of 30, co-authored 57 publications receiving 3166 citations. Previous affiliations of Hiranthi Jayasuriya include New York Botanical Garden.

Papers
More filters
Journal ArticleDOI

Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties.

TL;DR: Platencin shows potent in vivo efficacy without any observed toxicity, emphasizing the fact that more antibiotics with novel structures and new modes of action can be discovered by using this antisense differential sensitivity whole-cell screening paradigm.
Journal ArticleDOI

Isolation, structure, and absolute stereochemistry of platensimycin, a broad spectrum antibiotic discovered using an antisense differential sensitivity strategy.

TL;DR: It was determined that potential reactivity of the enone moiety does not play a key role in the biological activity of platensimycin and cyclohexenone ring conformation renders for the stronger binding interaction with the enzyme.
Journal ArticleDOI

Discovery of a Small Molecule That Inhibits Cell Division by Blocking FtsZ, a Novel Therapeutic Target of Antibiotics *

TL;DR: Viriditoxin exhibited broad-spectrum antibacterial activity against clinically relevant Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci, without affecting the viability of eukaryotic cells.